As it has been shown that approximately 80% of IBD risk loci also fall within intergenic or intronic regions of the genome (3), we analyzed whether IBD risk loci were enriched within the differentially accessible regions of CD4 T cells from tissue biopsies and in vitro polarized CD4 T cell subpopulations. Here, CD4 is linked to inflammatory bowel disease.